Abstract
Defects in renal tubular epithelial cell repair contribute to renal ischemia reperfusion injury, cause acute kidney damage, and promote chronic renal disease. The matricellular protein thrombospondin-1 and its receptor CD47 are involved in experimental renal ischemia reperfusion injury, although the role of this interaction in renal recovery is unknown. We found upregulation of self-renewal genes (transcription factors Oct4, Sox2, Klf4 and cMyc) in the kidney of CD47-/- mice after ischemia reperfusion injury. Wild-type animals had minimal self-renewal gene expression, both before and after injury. Suggestive of cell autonomy, CD47-/- renal tubular epithelial cells were found to increase expression of the self-renewal genes. This correlated with enhanced proliferative capacity compared with cells from wild-type mice. Exogenous thrombospondin-1 inhibited self-renewal gene expression in renal tubular epithelial cells from wild-type but not CD47-/- mice, and this was associated with decreased proliferation. Treatment of renal tubular epithelial cells with a CD47 blocking antibody or CD47-targeting small interfering RNA increased expression of some self-renewal transcription factors and promoted cell proliferation. In a syngeneic kidney transplant model, treatment with a CD47 blocking antibody increased self-renewal transcription factor expression, decreased tissue damage, and improved renal function compared with that in control mice. Thus, thrombospondin-1 via CD47 inhibits renal tubular epithelial cell recovery after ischemia reperfusion injury through inhibition of proliferation/self-renewal.
Original language | English (US) |
---|---|
Pages (from-to) | 334-347 |
Number of pages | 14 |
Journal | Kidney international |
Volume | 90 |
Issue number | 2 |
DOIs | |
State | Published - Aug 1 2016 |
Funding
This work was supported by NIH grants P01 HL103455, R01 HL-108954, 1R01HL112914-01A1, and P30-DK079307 (JSI); a C.J. Martin Award, an AHA award 13POST14520003, an American Society of Transplantation Basic Science Fellowship, and a Joseph A. Patrick Fellowship in Transplantation (Starzl Transplant Institute) (NMR). This work was also supported by the Institute for Transfusion Medicine, the Hemophilia Center of Western Pennsylvania, and the Heart, Blood, Lung, and Vascular Medicine Institute of the University of Pittsburgh (JSI).
Keywords
- CD47
- OSKM
- ischemia-reperfusion injury
- kidney
- self-renewal
- thrombospondin-1
ASJC Scopus subject areas
- Nephrology